STK17B and neoplasm: A further subgroup analysis showed that low STK17B was correlated with worse OS in N and M Stage, pathologic stage, radiation therapy, gender, race, melanoma ulceration, age, melanoma Clark level, Breslow depth, tumor site, BRAF status of SKCM patients (Fig 2).